Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9GK0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,691
Award facts
- Contract value 100% obligated
- $42,691.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $42,691.38 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on December 18, 2025, with an ultimate completion date of December 19, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat various inflammatory conditions, including atopic dermatitis, asthma, and chronic rhinosinusitis.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen has demonstrated consistent capability to meet federal procurement requirements through open competition. The company supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs and other government healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. The contract reflects DLA's ongoing pharmaceutical supply chain modernization efforts under its Pharmaceutical Prime Vendor Global Program.
Quick answers
Who was awarded contract SPE2DR26F9GK0?
SPE2DR26F9GK0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26F9GK0 worth?
The government has obligated $42,691 on SPE2DR26F9GK0.
Is contract SPE2DR26F9GK0 an order under another contract?
Yes. SPE2DR26F9GK0 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9GK0 competed?
The extent of competition for SPE2DR26F9GK0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award